UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 1, 2016
PRA Health Sciences, Inc.
(Exact name of registrant as specified in its charter)
Delaware | | 001-36732 | | 46-3640387 |
(State or Other
Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer
Identification No.) |
4130 ParkLake Avenue
Suite 400
Raleigh, NC 27612
(919) 786-8200
(Address, including zip code, and telephone number,
including area code, of registrant’s principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission of Matters to a Vote of Security Holders.
(a) (b)
On June 1, 2016, PRA Health Sciences, Inc. (the “Company”) held its 2016 annual meeting of stockholders. A quorum was present at the meeting, as required by the Company’s Amended and Restated Bylaws. The immediately following charts set forth the number of votes cast for and against, and the number of abstentions votes and broker non-votes, with respect to each matter voted upon by the stockholders.
Proposal 1 — Election of Directors
The following three individuals were elected to the Company’s Board of Directors to serve as Class II directors until the Company’s 2019 annual meeting of stockholders and until their successors have been duly elected and qualified.
| | Votes
For | | Votes
Withheld | | Broker
Non-Votes | |
Jeffrey T. Barber | | 57,373,570 | | 249,084 | | 556,080 | |
Linda S. Grais, M.D. | | 57,201,016 | | 421,638 | | 556,080 | |
Ali J. Satvat | | 44,654,905 | | 12,967,749 | | 556,080 | |
Proposal 2 — Ratification of the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for 2016
The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016 was ratified.
Votes
For | | Votes
Against | | Votes
Abstained | |
58,165,377 | | 7,733 | | 5,624 | |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PRA Health Sciences, Inc. |
| | |
| Date: June 2, 2016 | | |
| By: | /s/ Linda Baddour |
| Name: | Linda Baddour |
| Title: | Executive Vice President, Chief Financial Officer and Secretary |
| | | |
3
